The DOI matches its Crossref record; 42 of the 50 references it cites were found in a registry or an index.
Relationship Between Non-small Cell Lung Cancer FDG Uptake at PET, Tumor Histology, and Ki-67 Proliferation Index
Open accessAbstract
Introduction We compared primary non-small cell lung cancer (NSCLC) F-fluorodeoxyglucose (FDG) uptake at positron emission tomography (PET) to tumor histologic features and Ki-67 proliferation index. This large, prospectively-recruited patient cohort has previously been analyzed based on differences in FDG uptake across stage groups; the current analysis adds further dimensions to this characterization. Materials and methods One hundred seventy-eight patients with potentially-resectable NSCLC were scanned with FDG PET before therapy. A partial volume correction algorithm was used to correct FDG uptake values for their dependence on tumor size. Primary tumor resection specimens, core biopsies, and biopsies of metastatic lymph nodes were used to assess each tumor's NSCLC histologic subtype, degree of differentiation, and Ki-67 proliferation index. Results Bronchioalveolar carcinomas were found to have lower FDG uptake at PET and lower Ki-67 scores than any other histologic subtype. Non-bronchioalveolar adenocarcinomas had lower FDG uptake and Ki-67 scores than squamous cell carcinomas or large cell undifferentiated carcinomas. Better differentiated NSCLCs had lower FDG uptake and Ki-67 scores than more poorly differentiated NSCLCs. There was a significant positive correlation between FDG uptake and Ki-67 scores. Partial volume correction increased the strength of this correlation, while also diminishing the strong positive correlation between FDG uptake and tumor size. Conclusions There are significant differences in NSCLC FDG uptake across histologic subtypes and differentiation groups. These differences parallel nearly identical differences in Ki-67 scores, implying that differences in NSCLC tumor cell proliferation may give rise to commensurate differences in tumor glucose metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“or benign lesions and well-differentiated malignant lesions with low [18F]FDG avidity [122,123,124,125].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [124]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R. L., Ward, E. M., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,309
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · CHEST Journal · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
Winton, T. L., Livingston, R. B., Johnson, D. H., Rigas, J. R., Johnston, M., Butts, C. A., Cormier, Y. F., Goss, G., Inculet, R., Vallières, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043623 · Cited by 1,810
Self-citationDwamena, B. A., Sonnad, S. S., Angobaldo, J. O., & Wahl, R. L. (1999) · Radiology · doi:10.1148/radiology.213.2.r99nv46530 · Cited by 648
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Buck, A. K., Halter, G., Schirrmeister, H., Kotzerke, J., Wurziger, I., Glatting, G., Mattfeldt, T., Neumaier, B., Reske, S. N., & Hetzel, M. (2003) · PubMed · Cited by 403
Strauss, G. M., Herndon, J. E., Maddaus, M. A., Johnstone, D. W., Johnson, E. A., Watson, D. M., Sugarbaker, D. J., Schilsky, R. L., & Green, M. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.7019 · Cited by 380
Key, G., Becker, M., Baron, B., Duchrow, M., Schlüter, C., Flad, H. D., & Gerdes, J. (1993) · PubMed · Cited by 376
Downey, R. J., Akhurst, T., Gönen, M., Vincent, A., Bains, M. S., Larson, S. M., & Rusch, V. W. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.109 · Cited by 358
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Higashi, K., Ueda, Y., Seki, H., Yuasa, K., Oguchi, M., Noguchi, T., Taniguchi, M., Tonami, H., Okimura, T., & Yamamoto, I. (1998) · PubMed · Cited by 351
Vesselle, H. J., Schmidt, R. A., Pugsley, J. M., Li, M., Kohlmyer, S. G., Vallires, E., & Wood, D. E. (2000) · PubMed · Cited by 351
Self-citation
Research works printed but not linked: 2
- Rao, 2000, Prevalence of metastatic disease and impact of PET on management in staging lung cancer: a clinical series of 400 patients, J Nucl Med, 41, 75P
- Kohlmyer, 2000, Comparison of recovery coefficients for PET based on maximum and average ROI pixel values, Eur J Nuclear Med, 27, 977
Cited by
Sorted by citations
Travis, W. D., Brambilla, E. M., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Schil, P. E. V., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,834
Erlandsson, K., Buvat, I., Pretorius, P. H., Thomas, B. A., & Hutton, B. F. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/21/r119 · Cited by 731
Hwangbo, B., Kim, S. K., Lee, H., Lee, H., Kim, M. S., Lee, J. M., Kim, H.-Y., Lee, G.-K., Nam, B., & Zo, J. I. (2009) · CHEST Journal · doi:10.1378/chest.08-2019 · Cited by 164
Lee, H. Y., & Lee, K. S. (2011) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e3181fbaa64 · Cited by 162
18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy
Ford, E. C., Herman, J. M., Yorke, E. D., & Wahl, R. L. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055780 · Cited by 136
Metadata
- Authors
- Vesselle, H., Salskov, A., Turcotte, E., Wiens, L., Schmidt, R., Jordan, C. D., Vallières, E., & Wood, D. E.
- Affiliations
- University of Washington (US)
- Corresponding author
- Vesselle, Hubert
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 3
- Issue
- 9
- Pages
- 971-978
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W1979039258
- Semantic Scholar
- 47e32ad0bcc9c0453f63876438f1cdc0803650f5
- Cited by
- 165
- References
- 50
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 9 · 2022: 13 · 2021: 9 · 2020: 9 · 2019: 4 · 2018: 16 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 13 · 2013: 10 · 2012: 13
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Thoracic Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington
- National Cancer Institute (1R01 CA80907, R01CA115559, R01CA080907, R01CA107264)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- non-small cell lung cancer, FDG uptake, positron emission tomography, Ki-67 proliferation index, tumor histologic subtype, tumor differentiation, bronchioloalveolar carcinoma, adenocarcinoma, squamous cell carcinoma, tumor glucose metabolism, partial volume correction, tumor size
- MeSH terms
- Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Female, Humans, Lung Neoplasms, Male, Neoplasm Staging, Prognosis, Prospective Studies, Radiography, Thoracic, Tomography, X-Ray Computed, Biomarkers, Tumor, Cohort Studies, Carcinoma, Large Cell, Radiopharmaceuticals, Ki-67 Antigen, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
